Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$487M |
| 2 |
Apple
AAPL
|
+$481M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$251M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$201M |
| 5 |
PayPal
PYPL
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$598M |
| 2 |
Procter & Gamble
PG
|
+$447M |
| 3 |
PepsiCo
PEP
|
+$307M |
| 4 |
Coca-Cola
KO
|
+$245M |
| 5 |
Applied Materials
AMAT
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Healthcare | 14.91% |
| 3 | Financials | 11.34% |
| 4 | Communication Services | 8.3% |
| 5 | Consumer Discretionary | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCBC
2951
DELISTED
Macatawa Bank Corp
MCBC
| $159K | ﹤0.01% |
17,145
+656
| +4% | +$6.08K |
|
2952
AnaptysBio
ANAB
$1.58B
| $159K | ﹤0.01% |
7,819
-6,664
| -46% | -$135K |
|
2953
Scilex Holding
SCLX
$46.9M
| $158K | ﹤0.01% |
810
-290
| -26% | -$80K |
|
2954
FTAI Infrastructure
FIP
$441M
| $158K | ﹤0.01% |
42,797
+42,097
| +6,014% | +$137K |
|
2955
Nurix Therapeutics
NRIX
$2.41B
| $157K | ﹤0.01% |
15,754
-12,659
| -45% | -$129K |
|
|
ME
2956
DELISTED
23andMe Holding Co
ME
| $157K | ﹤0.01% |
4,473
-3,686
| -45% | -$147K |
|
2957
Vanguard International High Dividend Yield ETF
VYMI
$20.6B
| $156K | ﹤0.01% |
2,470
-2,555
| -51% | -$162K |
|
|
SEMR
2958
DELISTED
Semrush
SEMR
| $156K | ﹤0.01% |
+16,293
| New | +$144K |
|
2959
Cerus
CERS
$433M
| $155K | ﹤0.01% |
62,926
-48,175
| -43% | -$114K |
|
2960
Primis Financial Corp
FRST
$399M
| $154K | ﹤0.01% |
18,333
+4,402
| +32% | +$36.8K |
|
|
PETQ
2961
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $154K | ﹤0.01% |
10,167
-7,101
| -41% | -$91.1K |
|
2962
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $154K | ﹤0.01% |
700
-25
| -3% | -$5.21K |
|
|
CATC
2963
DELISTED
CAMBRIDGE BANCORP
CATC
| $154K | ﹤0.01% |
2,837
-1,407
| -33% | -$78.4K |
|
2964
Ocular Therapeutix
OCUL
$1.79B
| $154K | ﹤0.01% |
29,842
-21,233
| -42% | -$126K |
|
2965
Esquire Financial Holdings
ESQ
$1.12B
| $154K | ﹤0.01% |
3,366
-1,063
| -24% | -$43.6K |
|
2966
Bausch Health
BHC
$2.58B
| $154K | ﹤0.01% |
19,226
+565
| +3% | +$4.17K |
|
2967
Mobileye
MBLY
$2B
| $154K | ﹤0.01% |
4,000
| – | – |
|
2968
Brady Corp
BRC
$4.44B
| $153K | ﹤0.01% |
3,221
-29,367
| -90% | -$1.48M |
|
2969
Bowman Consulting
BWMN
$470M
| $152K | ﹤0.01% |
+4,771
| New | +$139K |
|
2970
Xeris Biopharma Holdings
XERS
$1.39B
| $152K | ﹤0.01% |
57,878
-30,977
| -35% | -$78.9K |
|
2971
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
| $151K | ﹤0.01% |
1,566
| – | – |
|
2972
Tiptree Inc
TIPT
$662M
| $151K | ﹤0.01% |
10,070
-5,085
| -34% | -$70.8K |
|
|
NPKI
2973
NPK International
NPKI
$1.06B
| $151K | ﹤0.01% |
28,887
-24,682
| -46% | -$102K |
|
2974
Evolution Petroleum
EPM
$132M
| $151K | ﹤0.01% |
+18,678
| New | +$138K |
|
2975
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
| $150K | ﹤0.01% |
+14,500
| New | +$150K |
|
Similar funds
Deutsche Bank's Q2 2023 Portfolio in Review
As of Q2 2023, Deutsche Bank held 4,099 positions worth $188B, up 4.7% from $180B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Deutsche Bank's Q2 2023 filing shows 196 new, 1,082 increased, 2,153 reduced and 296 closed positions. Its largest new stake was Kenvue: 376,607 shares worth $9.95M. The largest sale was Microsoft, an estimated $598M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q2 2023 buy was Kenvue: 376,607 shares worth $9.95M.
- Deutsche Bank added most to Meta Platforms (Facebook) in Q2 2023, an estimated $487M increase.
- Deutsche Bank's biggest Q2 2023 reduction was Microsoft, cutting an estimated $598M.
- Deutsche Bank fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $122M.
- Deutsche Bank's ten largest holdings make up 23% of its $188B portfolio in Q2 2023.
- Deutsche Bank opened 196 new positions and closed 296 in Q2 2023.
- Deutsche Bank's portfolio value rose 4.7% quarter-over-quarter to $188B.
Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.